The potent antiangiogenic and proinflammatory protein Endothelial Monocyte Activating Polypeptide II (EMAP II) has been described as a mediator of pulmonary vascular and alveolar formation and its expression is inversely related to the periods of vascularization and alveolarization in the developing lung. Hence the study of EMAP II could play a vital role in studying and devising appropriate therapeutics for diseases of aberrant lung development, such as BPD.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
100 μg | 約5 days | ¥ 85,500 |
500 μg | 約5 days | ¥ 342,000 |
1 mg | 約5 days | ¥ 569,500 |
説明 | The potent antiangiogenic and proinflammatory protein Endothelial Monocyte Activating Polypeptide II (EMAP II) has been described as a mediator of pulmonary vascular and alveolar formation and its expression is inversely related to the periods of vascularization and alveolarization in the developing lung. Hence the study of EMAP II could play a vital role in studying and devising appropriate therapeutics for diseases of aberrant lung development, such as BPD. |
Species | Mouse |
Expression Host | E. coli |
Tag | N-His |
Accession Number | P31230 |
別名 | p43, SCYE1, HLD3, EMAP-II, AIMP1, EMAP-2 |
Construction | Ala2-Lys310 |
Protein Purity | > 95% as determined by Tris-Bis PAGE |
分子量 | 35.1 kDa (predicted). The protein migrates to 42-46 kDa based on Tris-Bis PAGE result. |
Endotoxin | < 1 EU/μg by the LAL method. |
Formulation | Supplied as 0.22 μm filtered solution in 20 mM Tris, 500 mM NaCl, 10% Glycerol (pH 8.0). |
Stability & Storage |
It is recommended to store the product under sterile conditions at -70℃ or lower. Samples are stable for up to 12 months at -80℃. Please avoid multiple freeze-thaw cycles and store products in aliquots. |
Shipping |
In general, Lyophilized powders are shipping with blue ice. Solutions are shipping with dry ice. |
Research Background | The potent antiangiogenic and proinflammatory protein Endothelial Monocyte Activating Polypeptide II (EMAP II) has been described as a mediator of pulmonary vascular and alveolar formation and its expression is inversely related to the periods of vascularization and alveolarization in the developing lung. Hence the study of EMAP II could play a vital role in studying and devising appropriate therapeutics for diseases of aberrant lung development, such as BPD. |
bottom
Please read the User Guide of Recombinant Proteins for more specific information.
EMAP-II/AIMP1 Protein, Mouse, Recombinant (His) SCYE 1 AIMP 1 AIMP-1 HLD 3 EMAP 2 p43 SCYE1 HLD3 SCYE-1 EMAP-II HLD-3 AIMP1 EMAP-2 EMAP2 recombinant recombinant-proteins proteins protein